Clinical trial Recruiting at 1 site Observational Ages 10 to 17

Understanding Proteins and Skepsis Progression in Adolescent Scoliosis

Official title: UNderstanding the Causes Of Idiopathic Scoliosis Through the Longitudinal Analysis of Proteomic Markers: the UNCOIL Study

Run by University of Colorado, Denver · NCT07634627 · Data updated 2026-11-12

Researchers will test blood protein markers to see if they can predict scoliosis progression in teens with AIS or neuromuscular scoliosis.

More Adolescent Idiopathic Scoliosis (AIS) trials

Quick facts

Study typeObservational
Ages10 Years to 17 Years
SexAll
Enrollment500 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Drugs / interventionsprednisone
Locations1 site (Aurora, Colorado)
StatusRecruiting
StartedDecember 5, 2024
Main results expectedDecember 2029
Study endsDecember 2031
Registry record updatedJune 23, 2026
Trial IDNCT07634627 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 10-17 year-olds with idiopathic or neuromuscular scoliosis (Cobb angle 10-50°) seen at Children's Hospital Colorado.

Probably not a fit

Patients with Cobb angles above 50°, certain genetic conditions affecting bones or muscles, or those on medications that alter protein expression may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects clinical data and blood samples from 10-17 year-olds with idiopathic or neuromuscular scoliosis at a Children's Hospital Colorado location. Participants have two visits 6-12 months apart, during which demographic and clinical information is recorded and about 3 tablespoons of blood are drawn to measure protein biomarkers. The goal is to identify protein patterns that are associated with scoliosis progression and to compare biomarker levels between progressive and non-progressive cases, AIS versus non-AIS, and scoliosis due to neuromuscular conditions. Findings may help clarify biological factors linked to curve progression and differentiate AIS from other forms of scoliosis.

Why it matters

Potential benefit: If successful, the study could help identify biomarkers that predict scoliosis progression and guide personalized monitoring or future therapies.

How similar studies have gone: Previous studies in proteomics have shown promise in signaling musculoskeletal disease processes, but this specific approach in AIS and neuromuscular scoliosis is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients 10-17 years old with idiopathic or neuromuscular scoliosis with a cobb angle of 10-50° that are currently being seen for their scoliosis at a Children's Hospital Colorado location

Exclusion Criteria:

* Children diagnosed with certain genetic conditions that affect the bones or muscles (Turner syndrome, down syndrome, Marfan syndrome, osteogenesis imperfecta, muscular dystrophy, Ehlers-Danlos syndrome, VATER/VACTERL syndrome, Rett syndrome, Prader Willi syndrome, or Angelman syndrome)
* Patients with congenital scoliosis, early onset scoliosis (diagnosed before 9 years old), or those who have spine surgery scheduled prior to the first study visit
* Patients whose spinal curve is \>50 degrees
* Those taking medications that may influence protein expression (baclofen, prednisone/corticosteroids, antiepileptic medications, diazepam, tizanidine, and/or dantrolene)
* Patients who are pregnant
* Patients with neurocognitive disorders who are non-verbal and/or non-ambulatory
* Patients who are not receiving care for scoliosis at a Children's Hospital Colorado location

Where it's running

  • Children's Hospital Colorado Anschutz
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.